Share Market News, Those who invested in this stock got a bumper return of 132 percent, all signs of further growth are visible – multibagger penny stock lincoln pharmaceuticals ltd stock gave bumper return of 132 percent in three years
[ad_1]
The company’s laboratory has been awarded ISO 9001:2015 certification. The growth of the company has increased due to these certifications and achievements. The company is now working on plans to expand its presence in the US and UK markets. Lincoln Pharmaceuticals Limited recently announced its Q1FY24 results, in which the company’s sales have increased by 10.5% to Rs 136 crore as compared to Q1FY23. At the same time, the company’s operating profit has increased by 23.5% to Rs 21 crore as compared to Q1FY23. Similarly, the company’s net profit jumped 26.6% to Rs 19 crore over Q1FY23. Furthermore, the company has been able to grow its sales by 10% (CAGR) and net profit by 12% (CAGR) during the same period.
The company has given a stupendous return of 72% in the last year and a significant return of 132% in the last 3 years. Additionally, the company has a ROCE of 21.8% and an ROE of 15.6%. Today i.e. on Friday, the company’s shares have seen a jump of more than one per cent. Investors can include this stock in their portfolio to earn profits.
This article is powered by Dalal Street Investment Journal, India’s No. 1 Investment Magazine. Click here to get regular updates about Winning Stocks and Recommendations.
(Disclaimer: This above is third party content and TIL hereby disclaims any and all warranties, express or implied, relating to the same. TIL does not guarantee, vouch for or endorse any of the above content or its accuracy nor is responsible for it in The content does not constitute any investment advice or solicitation of any kind. Users are advised to check with certified experts before taking any investment decision and take all steps necessary to ascertain that any information and content provided is correct, updated and verified. .)
[ad_2]
Source link
